These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19675140)

  • 1. Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy.
    McGuire JF; Rouen S; Siegfreid E; Wright DE; Dobrowsky RT
    Diabetes; 2009 Nov; 58(11):2677-86. PubMed ID: 19675140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of neuregulin-1 isoforms and downregulation of erbin are associated with Erb B2 receptor activation in diabetic peripheral neuropathy.
    Pan P; Dobrowsky RT
    Acta Neuropathol Commun; 2013 Jul; 1():39. PubMed ID: 24252174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor blocks the glucose-induced down-regulation of caveolin-1 expression in Schwann cells via p75 neurotrophin receptor signaling.
    Tan W; Rouen S; Barkus KM; Dremina YS; Hui D; Christianson JA; Wright DE; Yoon SO; Dobrowsky RT
    J Biol Chem; 2003 Jun; 278(25):23151-62. PubMed ID: 12679365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice.
    Urban MJ; Li C; Yu C; Lu Y; Krise JM; McIntosh MP; Rajewski RA; Blagg BS; Dobrowsky RT
    ASN Neuro; 2010 Aug; 2(4):e00040. PubMed ID: 20711301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
    Vareniuk I; Pavlov IA; Drel VR; Lyzogubov VV; Ilnytska O; Bell SR; Tibrewala J; Groves JT; Obrosova IG
    Exp Neurol; 2007 Jun; 205(2):425-36. PubMed ID: 17475250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
    Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
    Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
    Vareniuk I; Pavlov IA; Obrosova IG
    Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angelica injection promotes peripheral nerve structure and function recovery with increased expressions of nerve growth factor and brain derived neurotrophic factor in diabetic rats.
    Li R; Zhang J; Zhang L; Cui Q; Liu H
    Curr Neurovasc Res; 2010 Aug; 7(3):213-22. PubMed ID: 20560879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.
    Obrosova IG; Stavniichuk R; Drel VR; Shevalye H; Vareniuk I; Nadler JL; Schmidt RE
    Am J Pathol; 2010 Sep; 177(3):1436-47. PubMed ID: 20724598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes.
    Kellogg AP; Wiggin TD; Larkin DD; Hayes JM; Stevens MJ; Pop-Busui R
    Diabetes; 2007 Dec; 56(12):2997-3005. PubMed ID: 17720896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy.
    Urban MJ; Pan P; Farmer KL; Zhao H; Blagg BS; Dobrowsky RT
    Exp Neurol; 2012 May; 235(1):388-96. PubMed ID: 22465570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.
    Toth C; Rong LL; Yang C; Martinez J; Song F; Ramji N; Brussee V; Liu W; Durand J; Nguyen MD; Schmidt AM; Zochodne DW
    Diabetes; 2008 Apr; 57(4):1002-17. PubMed ID: 18039814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor.
    Yagihashi S; Yamagishi SI; Wada Ri R; Baba M; Hohman TC; Yabe-Nishimura C; Kokai Y
    Brain; 2001 Dec; 124(Pt 12):2448-58. PubMed ID: 11701599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of human HSP27 protects sensory neurons from diabetes.
    Korngut L; Ma CH; Martinez JA; Toth CC; Guo GF; Singh V; Woolf CJ; Zochodne DW
    Neurobiol Dis; 2012 Sep; 47(3):436-43. PubMed ID: 22569359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats.
    Miyauchi Y; Shikama H; Takasu T; Okamiya H; Umeda M; Hirasaki E; Ohhata I; Nakayama H; Nakagawa S
    Eur J Endocrinol; 1996 Apr; 134(4):467-73. PubMed ID: 8640299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
    Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
    Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats.
    Qiang X; Satoh J; Sagara M; Fukuzawa M; Masuda T; Sakata Y; Muto G; Muto Y; Takahashi K; Toyota T
    Diabetologia; 1998 Nov; 41(11):1321-6. PubMed ID: 9833940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress.
    Wu Y; Xu D; Zhu X; Yang G; Ren M
    Curr Neurovasc Res; 2017; 14(2):117-124. PubMed ID: 28393703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Mice Ubiquitously Overexpressing Human 15-Lipoxygenase-1: Effect of Diabetes on Peripheral Neuropathy and Treatment with Menhaden Oil.
    Coppey L; Obrosov A; Shevalye H; Davidson E; Paradee W; Yorek MA
    J Diabetes Res; 2021; 2021():5564477. PubMed ID: 33816635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.